Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:1216-1225

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Brien, K. D.
Right arrow Articles by Chait, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Brien, K. D.
Right arrow Articles by Chait, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease

(Circulation. 1996;94:1216-1225.)
© 1996 American Heart Association, Inc.


Articles

Oxidation-Specific Epitopes in Human Coronary Atherosclerosis Are Not Limited to Oxidized Low-Density Lipoprotein

Kevin D. O'Brien, MD; Charles E. Alpers, MD; John E. Hokanson, MPH, PhC; Shari Wang, BS; Alan Chait, MD

the Divisions of Cardiology (K.D.O'B.) and Metabolism, Endocrinology and Nutrition (J.E.H., S.W., A.C.), Department of Medicine; Department of Pathology (C.E.A.), School of Medicine; and Department of Epidemiology, School of Public Health and Community Medicine (J.E.H.), University of Washington, Seattle.

Correspondence to Kevin D. O'Brien, MD, Division of Cardiology, Box 356422, University of Washington, 1959 NE Pacific St, Seattle, WA 98195-6422. E-mail cardiac@u.washington.edu.

Background Previous small studies have demonstrated positive immunohistochemical staining in rabbit and human atherosclerotic plaques by antibodies that recognize oxidized low-density lipoprotein (OxLDL), but none have examined a large number of human coronary arteries or evaluated whether epitopes recognized by these antibodies might be present on plaque proteins other than OxLDL.

Methods and Results Immunohistochemistry was performed on atherosclerotic (n=87) and nonatherosclerotic (n=51) coronary arterial segments from 20 patients by use of monoclonal antibodies that recognize epitopes on macrophages, smooth muscle cells, apolipoprotein (apo) B, and OxLDL. Staining with the OxLDL antibody (Ox5) was much more prevalent in atherosclerotic than in control segments. Extracellular Ox5 staining colocalized with apo B, but cell-associated Ox5 staining occurred in the absence of cell-associated apo B staining, which suggests that cell-associated epitopes for Ox5 were on proteins other than LDL. Epitopes for Ox5 formed in vitro on two readily available non–apo B proteins, human serum albumin and apo A-I, when these proteins were incubated under conditions of oxidant stress with polyunsaturated but not monounsaturated fatty acids; furthermore, an antioxidant inhibited Ox5 epitope formation. Thus, epitopes for Ox5 can form on proteins other than apo B. Also, phorbol ester–treated macrophages cultured in apo B–free medium developed epitopes for Ox5.

Conclusions These findings are consistent with the hypothesis that atherosclerosis is associated with oxidative modification of proteins in addition to LDL, particularly cell-associated proteins, and that the antiatherosclerotic effects of antioxidants seen in some studies may not be solely due to prevention of LDL oxidation.


Key Words: apolipoproteins • macrophages • fatty acids • immunohistochemistry • antioxidants




This article has been cited by other articles:


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
K. Subramaniam and J.-P. Yared
Management of Pulmonary Hypertension in the Operating Room
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 119 - 136.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. J. Nicholls and S. L. Hazen
Myeloperoxidase and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1102 - 1111.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Kamido, H. Eguchi, H. Ikeda, T. Imaizumi, K. Yamana, K. Hartvigsen, A. Ravandi, and A. Kuksis
Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation
J. Lipid Res., January 1, 2002; 43(1): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Y. Chang, S. Potter-Perigo, T. N. Wight, and A. Chait
Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices
J. Lipid Res., May 1, 2001; 42(5): 824 - 833.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
W.S. Weintraub and D.G. Harrison
C-reactive protein, inflammation and atherosclerosis: do we really understand it yet?
Eur. Heart J., June 2, 2000; 21(12): 958 - 960.
[PDF]


Home page
J. Biol. Chem.Home page
K. L. Olin, S. Potter-Perigo, P. H. R. Barrett, T. N. Wight, and A. Chait
Lipoprotein Lipase Enhances the Binding of Native and Oxidized Low Density Lipoproteins to Versican and Biglycan Synthesized by Cultured Arterial Smooth Muscle Cells
J. Biol. Chem., December 3, 1999; 274(49): 34629 - 34636.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. D. O'Brien, C. Pineda, W. S. Chiu, R. Bowen, and M. A. Deeg
Glycosylphosphatidylinositol-Specific Phospholipase D Is Expressed by Macrophages in Human Atherosclerosis and Colocalizes With Oxidation Epitopes
Circulation, June 8, 1999; 99(22): 2876 - 2882.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Caligiuri, G. Liuzzo, L. M. Biasucci, and A. Maseri
Immune system activation follows inflammation in unstable angina: pathogenetic implications
J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1295 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. V. Bobryshev, R. S.A. Lord, T. Watanabe, and T. Ikezawa
The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions
Cardiovasc Res, October 1, 1998; 40(1): 191 - 205.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. S. Crawford, E. A. Kirk, M. E. Rosenfeld, R. C. LeBoeuf, and A. Chait
Dietary Antioxidants Inhibit Development of Fatty Streak Lesions in the LDL Receptor–Deficient Mouse
Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1506 - 1513.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Stengel, M. Antonucci, W. Gaoua, C. Dachet, P. Lesnik, D. Hourton, E. Ninio, M. J. Chapman, and S. Griglio
Inhibition of LPL Expression in Human Monocyte–Derived Macrophages Is Dependent on LDL Oxidation State : A Key Role for Lysophosphatidylcholine
Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1172 - 1180.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Calara, P. Dimayuga, A. Niemann, J. Thyberg, U. Diczfalusy, J. L. Witztum, W. Palinski, P. K. Shah, B. Cercek, J. Nilsson, et al.
An Animal Model to Study Local Oxidation of LDL and Its Biological Effects in the Arterial Wall
Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 884 - 893.
[Abstract] [Full Text] [PDF]